98%
921
2 minutes
20
Objective: The objective of this study was to investigate the presence of sarcopenia in fibromyalgia and whether there is any relationship between physical performance, disease activity, pain levels, and the existence of sarcopenia.
Method: Fifty female patients diagnosed with fibromyalgia syndrome (FMS) based on the classification criteria of the 2016 American College of Rheumatology and 50 healthy controls were admitted. Disease activity was evaluated with the Fibromyalgia Impact Questionnaire (FIQ) and pain level was evaluated with the Numerical Rating Scale. Sarcopenia was screened by the SARC-F questionnaire and the presence of sarcopenia was evaluated according to ISarcoPRM criteria. Furthermore, right-hand grip strength was evaluated with a dynamometer. Ultrasound was used to measure the anterior thigh muscle thickness on the quadriceps femoris.
Results: SARF-C scores were significantly higher in patients with FMS (p < 0.001). The presence of sarcopenia was found as 20 (40%) in FMS patients and 6 (12%) in healthy controls (p < 0.001). Right-hand grip strength was significantly different in patients with FMS (p = 0.007). Right anterior thigh muscle thickness was similar in the two groups (p = 0.875). A positive correlation was observed between FIQ score and SARF-C score in FMS patients with sarcopenia (r = 0.708, p < 0.001).
Conclusion: Sarcopenia was thought of as a common problem in patients with FMS. Evaluating sarcopenia in patients with FMS could enhance the effectiveness of FMS treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.24875/CIRU.24000354 | DOI Listing |
Liver Int
October 2025
Hannover Medical School, Department of Diagnostic and Interventional Radiology, Hannover, Germany.
Background And Aims: We aimed to ascertain the prevalence of sarcopenia in patients with primary sclerosing cholangitis (PSC) and to assess the prognostic value as a biomarker for disease outcome.
Methods: We collected data from 224 patients (148 male, 76 female; mean age 41 years) from January 2002 to December 2021, with a confirmed diagnosis of PSC who underwent magnetic resonance imaging (MRI). Muscle mass was quantified at the level of the third lumbar vertebra by measurement of psoas muscle thickness (PMT) and total psoas muscle area (PMA).
Inflamm Bowel Dis
September 2025
Pediatric Gastroenterology, Hepatology and Cystic Fibrosis Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Background: The effect of sarcopenia on clinical outcomes in children with Crohn's disease (CD) is unknown. We investigated whether sarcopenia at the diagnosis impacts the outcomes of children with CD.
Methods: This was a retrospective, single-center, case-control study of newly diagnosed children with CD undergoing magnetic resonance (MR) within 1 month from the diagnosis, from 2011 to 2022.
Inn Med (Heidelb)
September 2025
Institut für Biomedizin des Alterns, Friedrich-Alexander-Universität Erlangen-Nürnberg, Kobergerstraße 60, 90408, Nürnberg, Deutschland.
Nutrition is considered to play a key role in the multifactorial development of frailty. Conversely, frailty also affects nutrition. The aim of this article is to describe the interactions between these two entities in detail and to derive nutritional recommendations.
View Article and Find Full Text PDFFront Nutr
August 2025
Department of Clinical Laboratory, Lishui Municipal Central Hospital, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
Background: The HALP score, combining hemoglobin, albumin, lymphocyte, and platelet parameters, serves as a comprehensive indicator reflecting both inflammatory processes and nutritional conditions. Our investigation aimed to explore the association of this composite score with the prevalence of low muscle mass and associated mortality in the elderly American population.
Methods: The investigation incorporated information from 3,550 individuals aged ≥60 years enrolled in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2004.
J Frailty Sarcopenia Falls
September 2025
Healthy Ageing Programme, Alexandra Hospital, National University Health System, Singapore.
Objectives: The impact of sarcopenic obesity (SO) on frailty, cognition, and function compared to sarcopenia and obesity alone remains unclear. This study examined SO's effects on these domains in community-dwelling older adults.
Methods: We assessed 202 older adults (mean age 80.